Biological Drug Targets
A drug target is a molecule within the body, normally a protein that is naturally associated with a specific disease process which may be addressed by a drug to deliver a desired therapeutic effect. Biological target identification and approval are the most vital steps in developing a novel drug. Drug target validation includes demonstrating that DNA, RNA, or a protein molecule is specifically included in a disease process and can be a suitable target for improvement of a novel therapeutic drug. The most common drug targets of currently marketed drugs are proteins and nucleic acids.
- Pharmacophore
- Pharmaceutical drugs
- Chemical libraries
- Drug-receptor interaction
- Drug target identification
- Molecular medicine
Related Conference of Biological Drug Targets
June 22-23, 2026
5th World Congress on Medicinal Chemistry and Computer Aided Drug Design
Paris, France
July 27-28, 2026
19th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Rome, Italy
July 27-28, 2026
26th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Rome, Italy
August 20-21, 2026
27th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
London, UK
August 20-21, 2026
29th International Conference and Exhibition on Pharmaceutical Formulations
London, UK
August 20-21, 2026
32nd International Conference on Advanced Clinical Research and Clinical Trials
London, UK
November 19-20, 2026
14th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Dubai, UAE
November 26-27, 2026
5th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland